MARCONCINI, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 964
EU - Europa 347
AS - Asia 132
AF - Africa 25
OC - Oceania 8
Totale 1.476
Nazione #
US - Stati Uniti d'America 953
IT - Italia 132
SE - Svezia 68
CN - Cina 66
BG - Bulgaria 43
SG - Singapore 39
DE - Germania 36
GB - Regno Unito 27
SN - Senegal 17
FR - Francia 15
VN - Vietnam 15
AT - Austria 13
CA - Canada 11
AU - Australia 7
CI - Costa d'Avorio 7
KR - Corea 5
FI - Finlandia 4
IN - India 2
JP - Giappone 2
NL - Olanda 2
RU - Federazione Russa 2
TW - Taiwan 2
UA - Ucraina 2
BE - Belgio 1
CH - Svizzera 1
DK - Danimarca 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
TR - Turchia 1
Totale 1.476
Città #
Fairfield 177
Woodbridge 107
Ashburn 92
Houston 75
Seattle 67
Chandler 55
Cambridge 54
Wilmington 51
Sofia 43
Ann Arbor 39
New York 33
Beijing 31
Florence 23
Pisa 23
Princeton 23
Bremen 17
Dakar 17
Lawrence 17
Medford 15
Serra 15
Vienna 13
Des Moines 12
Dong Ket 10
Lancaster 10
London 10
Dearborn 8
Nanjing 8
Ottawa 8
Abidjan 7
Frankfurt am Main 6
Iowa City 6
San Diego 6
Columbus 5
Hefei 4
Los Angeles 4
Lucca 4
Boulder 3
Düsseldorf 3
Hebei 3
Kunming 3
Modena 3
Monza 3
Pistoia 3
Changsha 2
Chongqing 2
Guangzhou 2
Jiaxing 2
Montréal 2
Nanchang 2
Norwalk 2
Perth 2
Pescia 2
Piombino 2
Redwood City 2
Santa Croce sull'Arno 2
Seoul 2
Shenyang 2
Tianjin 2
Bari 1
Cascina 1
Castelnuovo Rangone 1
Chiesina Uzzanese 1
Chiswick 1
Cleveland 1
Copenhagen 1
Daejeon 1
Esslingen am Neckar 1
Gallicano 1
Geneva 1
Göttingen 1
Hendon 1
Izmir 1
Jacksonville 1
Jüchen 1
Lagos 1
Leawood 1
Marseille 1
Milan 1
Moscow 1
Ningbo 1
Notre Dame 1
Ogden 1
Positano 1
Prato 1
Pune 1
Rosignano Marittimo 1
Rotterdam 1
Sainte-Colombe-sur-Gand 1
San Francisco 1
Santa Rosa 1
Shanghai 1
Singapore 1
Taipei 1
Toronto 1
Viareggio 1
Wandsworth 1
Washington 1
Yellow Springs 1
Totale 1.186
Nome #
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC 236
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients 159
EZH2 Expression in Intestinal Neuroendocrine Tumors 123
Small-bowel neuroendocrine tumor and retroperitoneal fibrosis: Efficacy of octreotide and tamoxifen 103
OCTREOTIDE LAR SUITABLE TREATMENT FOR G1-G2 THORACIC NEUROENDOCRINE TUMORS (T-NET): SINGLE CENTER EXPERIENCE 90
Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors 82
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable 82
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 76
Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 months. 74
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors 74
Effect of age on melanoma risk, prognosis and treatment response 74
Current status and perspectives in immunotherapy for metastatic melanoma 69
Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma 67
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 64
Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors 61
EARLY AND COMPLETE CLINICAL RESPONSE TO SUNITINIB IN A PATIENT WITH METASTATIC RENAL CANCER 42
Real world treatment practice in patients with advanced melanoma in the nivolumab era: five novel Italian case reports and a literature review 29
Multidisciplinary Team Session - Head & Neck cancer MDT meeting 12
Epidemiology of Merkel cell carcinoma in Tuscany (Italy), 2006-2021 12
TGF-β mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma 4
Totale 1.533
Categoria #
all - tutte 4.455
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.455


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201967 0 0 0 0 0 0 0 0 0 0 36 31
2019/2020463 37 58 10 41 56 52 47 43 47 30 37 5
2020/2021148 14 7 2 17 10 6 0 6 31 19 19 17
2021/2022153 2 2 5 1 35 29 4 5 17 1 4 48
2022/2023262 24 72 19 21 8 23 1 11 44 1 34 4
2023/2024165 4 14 38 7 20 46 16 4 2 11 3 0
Totale 1.533